CTRB Antibodies

Santa Cruz Biotechnology features a diverse variety of CTRB Antibodies for advancing research initiatives. Monoclonal CTRB Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CTRB, or chymotrypsinogen B, plays a crucial role in the digestive system by aiding in the breakdown of proteins into peptides. Its proper function is essential for nutrient absorption and overall metabolic health. Dysregulation of CTRB has been linked to various gastrointestinal disorders, making it a significant target for research in understanding these conditions. CTRB research has revealed important insights into digestive enzyme regulation and pancreatic function. Understanding CTRB mechanisms can lead to improved treatments for digestive disorders and metabolic conditions. Recent studies have highlighted CTRB's potential involvement in inflammatory responses and tissue repair processes. Santa Cruz Biotechnology monoclonal CTRB Antibodies enable researchers worldwide to advance scientific understanding of digestive health and disease mechanisms.